Barclays Reaffirms “Overweight” Rating for St. Jude Medical

Posted on by

‘s stock had its “overweight” rating reiterated by research analysts at Barclays in a research note issued to investors on Monday, Marketbeat.com reports. They currently […]

Read the original post by AmericanBankingNews.com